Status:
COMPLETED
Assessment of Novel Measurement and Fitting Methods to Determine Their Reliability, Validity and Application - Sonova2018_34
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A methodical evaluation of novel measurement and fitting methods for individualizing CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on heari...
Eligibility Criteria
Inclusion
- Participants fulfilling all of the following inclusion criteria are eligible for the study:
- Adult hearing impaired persons (minimum age: 18 years) with and without (experience with) hearing aids
- Healthy outer ear (without previous surgical procedures)
- Ability to fill in a questionnaire (p/eCRF) conscientiously
- Informed Consent as documented by signature
- The presence of any one of the following exclusion criteria will lead to exclusion of the participant:
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend appointments
- Limited ability to describe listening impressions or to use hearing aids/ accessories
- Inability to produce a reliable hearing test result
- Massively limited dexterity
- Known psychological problems
- Known central hearing disorders
Exclusion
Key Trial Info
Start Date :
October 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03755453
Start Date
October 11 2018
End Date
February 28 2019
Last Update
May 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonova AG
Stäfa, Canton of Zurich, Switzerland, 8712